Mereo BioPharma Group plc (ADR)

General ticker "MREO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $213.4M (TTM average)

Mereo BioPharma Group plc (ADR) does not follow the US Stock Market performance with the rate: -23.9%.

Estimated limits based on current volatility of 4.0%: low 0.26$, high 0.28$

Factors to consider:

  • Total employees count: 39 (+8.3%) as of 2025
  • Top business risk factors: Operational and conduct risks, Clinical trial failure, Regulatory and compliance, Funding shortfall, Key person loss
  • Current price 75.1% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.07$, 2.59$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.04$, 2.48$]

Similar symbols

Short-term MREO quotes

Long-term MREO plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $10.00MM $0.00MM $0.50MM
Operating Expenses $38.42MM $47.36MM $38.76MM
Operating Income $-28.42MM $-47.36MM $-38.26MM
Non-Operating Income $-1.58MM $4.11MM $-3.62MM
Interest Expense $2.88MM $1.37MM $0.26MM
R&D Expense $17.42MM $20.93MM $17.77MM
Income(Loss) $-30.00MM $-43.25MM $-41.88MM
Taxes $-0.53MM $0.00MM $0.00MM
Net Income(Loss)* $-29.47MM $-43.25MM $-41.88MM
Stockholders Equity $50.54MM $60.97MM $40.92MM
Assets $66.50MM $76.39MM $45.92MM
Operating Cash Flow $-21.13MM $-32.83MM $-30.97MM
Capital expenditure $0.42MM $0.70MM $0.02MM
Investing Cash Flow $-0.42MM $-0.70MM $-0.02MM
Financing Cash Flow $7.97MM $46.15MM $0.33MM
Earnings Per Share** $-0.22 $-43,253,000,000,000.00 $-0.26
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.